Kutcho Copper’s 2024 Annual Review and 2025 Outlook
Kutcho Copper Corp. (TSXV: KC, OTCQX: KCCFF), based in Vancouver, British Columbia, has released its annual review detailing the progress of its high-grade copper-zinc development
Home
Page 177
Chesapeake Financial Shares Welcomes Dede Ramoneda to Its Board of Directors
Chesapeake Financial Shares Inc (OTCQX: CPKF) has announced the addition of Dede Ramoneda to its Board of Directors, a move that reflects the company’s commitment
Western Uranium & Vanadium Highlights Key Achievements in 2024
Western Uranium & Vanadium Corp. (CSE: WUC, OTCQX: WSTRF) has outlined a series of significant accomplishments from 2024, reflecting its commitment to enhancing uranium and
Calidi Biotherapeutics Secures $4.25 Million in Public Offering to Advance Cancer Immunotherapy
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI), a clinical-stage biotechnology firm specializing in targeted immunotherapies, has successfully priced its public offering of 5,000,000 shares of common
Vaso Corporation Strengthens Leadership Team with Key Appointments
Vaso Corporation (OTCQX: VASO), a prominent player in human capital, information technology, and MedTech, has announced significant changes to its executive leadership team and Board
Salem Media Group Expands Faith-Based Offerings with Your Nightly Prayer Podcast
Salem Media Group (OTCQX: SALM), a multimedia company specializing in Christian and conservative content, has recently integrated the Your Nightly Prayer podcast into its LifeAudio
VYRE Live and FUBU Studios Join Forces to Redefine Original Content Creation
VYRE Live, a leading event production and live streaming solution for the music industry and special events, has announced a strategic partnership with For Us
U.S. Markets Close to Honor President Jimmy Carter
On January 9, 2025, U.S. stock markets, including the New York Stock Exchange (NYSE) and Nasdaq, will remain closed in observance of a National Day
Silo Pharma Secures US Patent for Innovative PTSD Treatment and Gears Up for Clinical Trials
Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing novel therapies for psychiatric disorders, has recently received a Notice of Allowance from the
Integrating AI into Critical Sectors Such as Pharmaceuticals and Semiconductors
Absci Corporation (NASDAQ: ABSI), a leader in AI-driven drug discovery, has seen its stock price surge by over 45% in intraday trading following the announcement
